Literature DB >> 27059424

Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases.

L Borradori1,2, B Sutton1, P Shayesteh1, G A Daniels1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27059424     DOI： 10.1111/bjd.14642

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  29 in total

1.  The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer.

Authors:  James Randall Patrinely; Anna K Dewan; Douglas B Johnson
Journal:  BioDrugs       Date:  2020-08       Impact factor: 5.807

2.  Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase 2 clinical trial.

Authors:  Kathryn A Gold; Merrill S Kies; William N William; Faye M Johnson; J Jack Lee; Bonnie S Glisson
Journal:  Cancer       Date:  2018-03-26       Impact factor: 6.860

Review 3.  Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma.

Authors:  J Claveau; J Archambault; D S Ernst; C Giacomantonio; J J Limacher; C Murray; F Parent; D Zloty
Journal:  Curr Oncol       Date:  2020-08-01       Impact factor: 3.677

Review 4.  Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.

Authors:  Dai Ogata; Tetsuya Tsuchida
Journal:  Curr Treat Options Oncol       Date:  2019-03-14

Review 5.  Basal Cell Carcinoma: A Narrative Review on Contemporary Diagnosis and Management.

Authors:  Piyu Parth Naik; Munaf B Desai
Journal:  Oncol Ther       Date:  2022-06-21

6.  Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab.

Authors:  Samantha Venkatesh; Ali Al-Haseni; Debjani Sahni
Journal:  BMJ Case Rep       Date:  2019-08-02

Review 7.  [Cutaneous squamous cell carcinoma].

Authors:  U Leiter; R Gutzmer; M Alter; C Ulrich; A S Lonsdorf; M M Sachse; U Hillen
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

8.  Unresectable cutaneous squamous cell carcinoma of the forehead with MLH1 mutation showing dramatic response to Programmed Cell Death Protein 1 Inhibitor Therapy.

Authors:  Jed H Assam; Steven Powell; William C Spanos
Journal:  Clin Skin Cancer       Date:  2016-11-23

9.  Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma.

Authors:  Amit Mittal; Mike Wang; Aurobind Vidyarthi; Diana Yanez; Gabriela Pizzurro; Durga Thakral; Erin Tracy; Oscar R Colegio
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.996

Review 10.  Immune checkpoint inhibitors to treat cutaneous malignancies.

Authors:  Dulce M Barrios; Mytrang H Do; Gregory S Phillips; Michael A Postow; Tomoko Akaike; Paul Nghiem; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2020-05-24       Impact factor: 11.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.